TCW Group’s ResMed RMD Stock Holding History

TCW Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$545K	Buy	2,430 +118	+5%	+$29.4K	﹤0.01%	454
2025 Q4	$557K	Buy	+2,312	New	+$591K	﹤0.01%	450

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TCW Group's RMD Position: Q1 2026 in Review

TCW Group increased its ResMed (RMD) stake by 5.1% in Q1 2026, buying an estimated $29.4K and bringing the position to 2,430 shares worth $545K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

TCW Group first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $557K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

TCW Group held 2,430 shares of ResMed worth $545K as of Q1 2026.
TCW Group bought 118 ResMed shares in Q1 2026, an estimated $29.4K.
ResMed made up ﹤0.01% of TCW Group's portfolio in Q1 2026, its #454 holding.
TCW Group first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
TCW Group's ResMed position peaked at $557K in Q4 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.